Circ_0026123 promotes cisplatin resistance and progression of ovarian cancer by upregulating RAB1A through sequestering miR-543

aDepartment of Pharmacy, Northwest Women’s and Children’s Hospital, Xi’an, Shaanxi, 710061, People’s Republic of China

bDepartment of Pharmacy, Shaanxi Province Tumor Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, People’s Republic of China

Received 29 April 2022 Revised form accepted 29 April 2022

Correspondence to Peixi Zhao, Department of Pharmacy, Shaanxi Province Tumor Hospital of Xi’an Jiaotong University, No. 309 Yanta West Road, Yanta District, Xi’an 710061, Shaanxi, China, Tel: +86 13709140376; e-mail: [email protected]

留言 (0)

沒有登入
gif